New Pill Offers Hope Against Antibio-Resistant STI

New Delhi: A new pill has shown promise against antibiotic-resistant gonorrhoea -- a common sexually transmitted infection (STI) --, according to a study published in the journal The Lancet.

Cases of drug-resistant gonorrhoea have been increasing rapidly in recent years. If not treated promptly, gonorrhoea can result in serious complications, especially for women, in whom it can lead to increased risks of ectopic pregnancy and infertility.

The new pill gepotidacin -- developed by British drugmaker GSK and currently approved to treat urinary tract infections -- could be the new treatment against gonorrhoea, as there have been no new antibiotics since the 1990s for the STI.